Apogee Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Apogee Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $377.44M.
- Apogee Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $449.95M.
- Apogee Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $315.39M.
- Apogee Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2024 was $449.95M, a 42.67% increase from fiscal 2023.
- Apogee Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2023 was $315.39M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $377.44M 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $449.95M 10-K · filed 2026-03-02 | |
| 2024-03-31 | $449.95M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $315.39M 10-K · filed 2024-03-05 | |
| 2023-09-30 | $315.39M 10-Q · filed 2024-11-12 |